Polen Capital Management
EIKN

Polen Capital Management’s Eikon Therapeutics EIKN Stock Holding History

Polen Capital Management’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Buy
+35,742
New +$365K ﹤0.01% 194

Other funds holding EIKN

TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Polen Capital Management's EIKN Position: Q2 2026 in Review

Polen Capital Management opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 35,742 shares worth $466K. The stake represents ﹤0.01% of the portfolio and ranks #194 among its holdings.

12 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.

  • Polen Capital Management held 35,742 shares of Eikon Therapeutics worth $466K as of Q2 2026.
  • Eikon Therapeutics was a new Polen Capital Management position in Q2 2026.
  • Eikon Therapeutics made up ﹤0.01% of Polen Capital Management's portfolio in Q2 2026, its #194 holding.
  • 12 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.

Based on Polen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.